… -2 inhibitor Etoricoxib during concurrent chemo-radiotherapy schedule of cervical cancer
patients on tumour response and acute toxicities. … Cyclooxygenase-2 inhibitor studies in animal …

… or radiosensitization. Later we present several studies that focused on evaluating COX-2
inhibitors’ … with rofecoxib, a selective COX-2 inhibitor. Interestingly, after 1 year of treatment with …

… profile, and production of toxic metabolites from rofecoxib may contribute to its cardiac
toxicity [45]. Research suggests that both NSAIDs and COX-2 inhibitors are associated with an …

… One of such potential treatment pathways is cyclooxygenase-2 (COX-2) inhibition, particularly
… The issue of a potential radiosensitizing effect of celecoxib on several types of cancer has …

… , demonstrating that radiosensitization by celecoxib occurs in … had no effect on the
radiosensitizing effects of celecoxib. Thus, … Inhibition of cyclooxygenase-2 by rofecoxib attenuates …

… radiosensitizer in high-grade glioma. Some studies showed synergism of anti-inflammatory
cyclooxygenase-inhibitors with microtubule inhibitors … Rofecoxib is withdrawn from the market…

… -2, also known as cyclooxygenase-2 or COX-2, is an enzyme that … The radiosensitizing effect
of celecoxib in the presence of … administration of rofecoxib and creatine inhibited the striatal …

… The radiosensitizing effect of celecoxib in the presence of … administration of rofecoxib and
creatine inhibited the striatal … application of specific cyclooxygenase‐2 inhibitors. Arthritis …

… In the RTOG 9501 trial, the incidence of acute toxicity of grade 3 or greater was 34 % in the
… The COX - 2 inhibitor rofecoxib ( Vioxx ) was removed from the market in 2004 due to its risk…

… In 1990s, sulfonamide cyclooxygenase inhibitors rofecoxib… parallel solid-phase synthesis
to develop library of cyclic guanidine-linked sulfonamide derivatives as LMTK3 kinase inhibitors…